Unraveling tumor cell‑tumor microenvironment crosstalk through antibody array technologies (Review)

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• The tumor microenvironment (TME) comprises tumor cells, stromal cells, immune cells, and extracellular components.
• The TME significantly influences tumor growth, invasion, treatment resistance, and patient prognosis.
• Cell-to-cell communication within the TME is mediated by a complex network of secreted proteins like cytokines and chemokines.

Purpose of the Study:

• To review recent findings on tumor cell and TME communication.
• To identify key secreted proteins driving tumor progression and therapeutic resistance.
• To discuss the role of high-throughput antibody arrays in understanding TME signaling networks.

Main Methods:

• Review of current scientific literature on the tumor microenvironment and secreted proteins.
• Focus on the application of antibody arrays and multiplex immunoassays.
• Integration of findings from cellular and molecular biology techniques.

Main Results:

• The TME actively promotes tumor proliferation, invasion, and immune evasion through secreted signaling molecules.
• Specific secreted proteins are crucial for tumor progression and the development of resistance to therapies.
• High-throughput antibody arrays enable simultaneous screening of numerous secreted proteins in complex biological samples.

Conclusions:

• Understanding the intricate signaling networks within the TME is vital for advancing cancer research.
• Antibody arrays are powerful tools for dissecting these complex communication pathways.
• Further research into TME-secreted proteins can lead to novel therapeutic strategies.